NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NCT02007655

CompletedN/A

Sponsor: Bristol-Myers Squibb

Conditions: NonValvular Atrial Fibrillation

Interventions: Eliquis

Countries: Japan

The primary objectives of this study are: * To estimate the incidence rate of unexpected adverse events * To characterize the bleeding events and assess risk factors of bleeding * To identify ancillary baseline variables that may also be associated with adverse outcomes

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.

Inclusion Criteria:

* Patients who are beginning to receive the treatment with this product under the approved indications, dosage, and administration will be included in this study

Exclusion Criteria:

* Patients who are receiving Eliquis outside of its approved indication will be excluded from this study

Locations (1)

Toyama, Toyama, Japan